Meeting
2014 Genitourinary Cancers Symposium
Independent validation of a genomic classifier in an at-risk population of men conservatively managed after radical prostatectomy.
Authors
Eric A. Klein
Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH
Eric A. Klein , Jianbo Li , Andrew J. Stephenson , Kasra Yousefi , Michael W. Kattan , Cristina Magi-Galluzzi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 16)
DOI
10.1200/jco.2014.32.4_suppl.16
Abstract #
16
Poster Bd #
A8
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Efficacy of early and delayed radiation in a prostatectomy cohort adjusted for genomic and clinical risk.
First Author: Robert Den
Poster
2015 Genitourinary Cancers Symposium
A genomic classifier to improve prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
First Author: Eric A. Klein
Poster
2014 Genitourinary Cancers Symposium
Validation of a genomic classifier for predicting biochemical failure following postoperative radiation therapy in high-risk prostate cancer.
First Author: Robert Benjamin Den
Poster
2023 ASCO Genitourinary Cancers Symposium
Evaluating p53 nuclear expression and prostate cancer progression in a predominantly African American cohort.
First Author: William Gesztes